Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TEX13B | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-06 |
mRNA | ABHD4 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-06 |
mRNA | CERCAM | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
mRNA | SULF1 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-06 |
mRNA | LAMB2 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
mRNA | GTF3C6 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
mRNA | PXDC1 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
mRNA | SNTA1 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-06 |
mRNA | RPL5 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
mRNA | HDAC2 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |